Project Grant HT94252410698
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
The Pennsylvania State University will receive $979,599 from the Defense Health Agency through September 1, 2023 to August 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). The project aims to develop a novel approach to target metabolic vulnerabilities in metastatic lung cancer. Through this funding, Penn State researchers will investigate medical solutions for cancer on the battlefield and transform healthcare for service members and the public...
The U.S. Defense Health Agency awarded a $384,063 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Pennsylvania State University (Penn State) for a 2-year period from February 1, 2025 to January 31, 2027. The grant funds research to directly genetically modify Plasmodium sporozoites using mRNA/lipid nanoparticles. This work aims to transform healthcare for military service members and the broader public through innovative biomedical research...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $829,986.00 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to conduct research titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". This 3-year grant, effective September 30, 2023, aims to advance innovative biomedical research into melanoma prevention...
The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
This federal Project Grant award of $654,090.00 from the Defense Health Agency is for the "CANCER CELL INTRINSIC REGULATION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BLADDER CANCER" research project at Pennsylvania State University's Milton S. Hershey Medical Center. The research, which runs from September 30, 2024 to September 29, 2026, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate innovative approaches to cancer...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...
This federal Project Grant award for $5,238,417.00, granted by the Department of Defense's Military Medical Research and Development program (CFDA 12.420), funds a multi-year research project titled "OPTIMIZING A SURVEILLANCE STRATEGY TO TACKLE BREAST CANCER DORMANCY AND MINIMAL RESIDUAL DISEASE". The award was made on Sep 15, 2023 to The Trustees Of The University Of Pennsylvania, with an ultimate completion date of Sep 14, 2027. A key sub-award was made to Trustees Of Indiana...
This Defense Health Agency (DHA) Project Grant award for $4,509,475.00, granted on Sep 15, 2023 under the Military Medical Research and Development program (CFDA 12.420), supports a 4-year research project titled "Optimizing a Surveillance Strategy to Tackle Breast Cancer Dormancy and Minimal Residual Disease" to be conducted by the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The objective of this research is...